Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma

Respiratory Medicine

Volumn 98, Issue 6, 2004, Pages 479-487

  Holgate, S T ^a,r   Bousquet, J ^b   Chung, K F ^c   Bisgaard, H ^d   Pauwels, R ^e   Fabbri, L ^f   Rabe, K ^g   Doherty, M ^h   Snell, N J C ⁱ   Cuss, F ^j   D'Amato, M ^k   Reginster, J Y ^l   Abadie, E ^m   Besthorn, K ^m   Braunstein, G ⁿ   Bremard Oury, C ^o   Calvo, G ^m   Didier, E ^h   Lopez Vidriero, M ^p   Rames, A ^q   Reiss, T ^j   more..

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^d Mental Health Services CPH   (Denmark)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h ASTRAZENECA   (United Kingdom)

ⁱ Bayer Pharma   (United Kingdom)

^j MERCK RESEARCH LABORATORIES   (United States)

^k Rotta Research Laboratorium   (Italy)

^l GREES ASBL   (Belgium)

^m EMEA ^*

ⁿ GSK

^o Aventis

^p BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^q ROCHE PRODUCTS LTD   (United Kingdom)

^r SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

more..

Author keywords

Asthma; Clinical trials; Drug registration

Indexed keywords

ADENOSINE PHOSPHATE; ALLERGEN; ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRADYKININ; BRONCHODILATING AGENT; CORTICOSTEROID; GLUCOCORTICOID; HISTAMINE; HYDROCORTISONE; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; LEUKOTRIENE; METHACHOLINE; OXYGEN; PLACEBO;

ACUTE DISEASE; ASTHMA; BRONCHOSPASM; CATARACT; CHILDHOOD DISEASE; CLINICAL PRACTICE; CLINICAL STUDY; CLINICAL TRIAL; COMORBIDITY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG CLASSIFICATION; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; EXERCISE TEST; EXPERIMENTATION; FORCED EXPIRATORY VOLUME; GERIATRIC DISORDER; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; INHALER; LUNG FUNCTION; METHODOLOGY; OSTEOPOROSIS; OUTCOMES RESEARCH; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROVOCATION TEST; QUALITY OF LIFE; REGISTRATION; RESPIRATORY TRACT INFLAMMATION; REVIEW; RHINITIS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

EID: 2542570941     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2003.12.005     Document Type: Article

References (20)

1. Holgate ST, Davies DE, Lackie PM, Wilson SJ, Puddicombe SM, Lordan JL. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000;105:193-204.
2. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-45.
3. Global Initiative for Asthma. Global strategy for asthma management and prevention. National Institutes of Health, National Heart, Lung and Blood Institute (Available from www.ginasthma.com).
4. Leong KP, Huston DP. Understanding the pathogenesis of allergic asthma using mouse models. Ann Allergy Asthma Immunol 2001;87:96-109 (quiz 10).
5. Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer CA, O'Byrne PM, et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 1999;160:594-9.
6. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-18.
7. Hargreave FE, Sterk P, Adelroth EC, Ramsdale EH, O'Byrne PM. Airway responsiveness to histamine or methacholine: advances in measurement and interpretation. Respiration 1986;2:72-6.
8. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD, et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993;16(Suppl):53-83.
9. Cockcroft DW. Airway responses to inhaled allergens. Can Respir J 1998;5(Suppl A):14A-7A.
10. Arshad SH. Bronchial allergen challenge: a model for chronic allergic asthma? Clin Exp Allergy 2000;30:12-5.
11. Bousquet J, Van-Cauwenberge P, Khaltaev N. Chairmen. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(Suppl):S1-125.
12. Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998;157:4-9.
13. Holt S, Suder A, Weatherall M, Cheng S, Shirtcliffe P, Beasley R. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. Br Med J 2001;323:253-6.
14. Stahl E. Correlation between objective measures of airway calibre and clinical symptoms in asthma: a systematic review of clinical studies. Respir Med 2000;94:735-41.
15. Santanello NC, Zhang J, Seidenberg B, Reiss TF, Barber BL. What are minimal important changes for asthma measures in a clinical trial? Eur Respir J 1999;14(1):23-7.
16. Juniper EF, O'Byrne PM, Ferrie PJ, King DR, Roberts JN. Measuring asthma control. Clinic questionnaire or daily diary? Am J Respir Crit Care Med 2000;162:1330-4.
17. Rutten-van-Molken MP, Custers F, van-Doorslaer EK, Jansen CC, Heurman L, Maesen FP, et al. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 1995;8: 888-98.
18. Juniper EF. Quality of life in adults and children with asthma and rhinitis. Allergy 1997;52:971-7.
19. Jadad AR, Moher M, Browman GP, Booker L, Sigouin C, Fuentes M, et al. Systematic reviews and meta-analyses on treatment of asthma: critical evaluation. Br Med J 2000;320:537-40.
20. Zanen P, Lammers JW. Sample sizes for comparative inhaled corticosteroid trials with emphasis on showing therapeutic equivalence. Eur J Clin Pharmacol 1995;48:179 84.